Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with rheumatoid arthritis: an exploratory analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with rheumatoid arthritis: an exploratory analysis ; volume:25 ; number:1 ; day:30 ; month:10 ; year:2023 ; pages:1-12 ; date:12.2023
Arthritis Research & Therapy ; 25, Heft 1 (30.10.2023), 1-12, 12.2023
- Creator
-
Bathon, Joan M.
Centola, Michael
Liu, Xiaoqian
Jin, Zhicheng
Ji, Weihua
Knowlton, Nicholas S.
Ferraz-Amaro, Iván
Fu, Qin
Giles, Jon T.
Wasko, Mary Chester
Stein, C. Michael
Van Eyk, Jennifer E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-023-03196-3
- URN
-
urn:nbn:de:101:1-2024011708291709528447
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bathon, Joan M.
- Centola, Michael
- Liu, Xiaoqian
- Jin, Zhicheng
- Ji, Weihua
- Knowlton, Nicholas S.
- Ferraz-Amaro, Iván
- Fu, Qin
- Giles, Jon T.
- Wasko, Mary Chester
- Stein, C. Michael
- Van Eyk, Jennifer E.
- SpringerLink (Online service)
Other Objects (12)
Common atherosclerosis genetic risk factors and subclinical atherosclerosis in rheumatoid arthritis: the relevance of disease duration
Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis
HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis
Prevalence and associated factors of subclinical atherosclerosis in rheumatoid arthritis at the university hospital of Kinshasa
Subclinical Cardiac Dysfunction in Rheumatoid Arthritis
Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis
Brachial artery flow-mediated dilation and carotid intima-media thickness for assessment of subclinical atherosclerosis in rheumatoid arthritis
Common atherosclerosis genetic risk factors and subclinical atherosclerosis in rheumatoid arthritis: the relevance of disease duration
Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis
HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis
Prevalence and associated factors of subclinical atherosclerosis in rheumatoid arthritis at the university hospital of Kinshasa
Subclinical Cardiac Dysfunction in Rheumatoid Arthritis
Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis
Brachial artery flow-mediated dilation and carotid intima-media thickness for assessment of subclinical atherosclerosis in rheumatoid arthritis
Common atherosclerosis genetic risk factors and subclinical atherosclerosis in rheumatoid arthritis: the relevance of disease duration
Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis
HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis
Prevalence and associated factors of subclinical atherosclerosis in rheumatoid arthritis at the university hospital of Kinshasa
Subclinical Cardiac Dysfunction in Rheumatoid Arthritis
Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis